Clinical trial of senolytics in humans

Kasia Goljanek-Whysall
Jan 9, 2019
1 min read

https://www.ncbi.nlm.nih.gov/pubmed/?term=Senolytics+in+idiopathic+pulmonary+fibrosis%3A+Results+from+a+first-in-human%2C+open-label%2C+pilot+study

Selectively ablating senescent cells using dasatinib and quercetin alleviates Idiopathic Pulmonary Fibrosis-related dysfunction in mice; this article explores the effects of dasatinib and quercetin in humans.

Recent Posts

See All

A great collection of articles on mechanisms of ageing

https://www.nature.com/collections/cjcbiibedc?utm_source=hybris&utm_medium=email&utm_content=internal&utm_campaign=NRRJ_2_DW_NRMCBageings...

Relationship of muscle and osteoarthritis

https://link.springer.com/article/10.1007%2Fs11926-019-08

micro(RNA)managing muscle wasting

Our mini review article on known and emerging mechanisms of muscle wasting with a focus on microRNAs: https://www.physiology.org/doi/abs...

Comments

Post: Blog2_Post